Fundraising FoxOncocross
1 known investors
Find your way into Oncocross
Sign up to see every warm intro you have to Oncocross
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oncocross team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Oncocross is a South Korean precision medicine company that uses an AI platform built on multi-omics data, with business spanning drug discovery, diagnostics, and clinical applications. It offers LC/MS-based multi-omics analysis, a digital bio-bank of clinical and pathology data, and AI tools for cancer detection and drug indication discovery.
Investors · 1
Frequently asked questions
- What does Oncocross do?
- Oncocross is a South Korean precision medicine company that uses an AI platform built on multi-omics data, with business spanning drug discovery, diagnostics, and clinical applications. It offers LC/MS-based multi-omics analysis, a digital bio-bank of clinical and pathology data, and AI tools for cancer detection and drug indication discovery.
- Who are Oncocross's investors?
- Oncocross's investors include Magna Investment.